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Pressure related complications such as abdominal wall hernias occur with relative frequency in patients on peritoneal dialysis.
Less frequently, a transudative pleural eﬀusion containing dialysate can develop. This phenomenon appears to be due to increased
intra-abdominal pressure in the setting of congenital or acquired diaphragmatic defects. We report three cases of pleuroperitoneal
leak that occurred within a nine-month period at our institution. We review the literature on this topic, and discuss management
options. The pleural eﬀusion resolved in one patient following drainage of the peritoneum and a switch to haemodialysis. One
patient required emergency thoracocentesis. The third patient developed a complex eﬀusion requiring surgical intervention.
The three cases highlight the variability of this condition in terms of timing, symptoms and management. The diagnosis of a
pleuroperitoneal leak is an important one as it is managed very diﬀerently to most transudative pleural eﬀusions seen in this
patient population. Surgical repair may be necessary in those patients who wish to resume peritoneal dialysis, or in those patients
with complex eﬀusions. Pleuroperitoneal leak should be considered in the diﬀerential diagnosis of a pleural eﬀusion, particularly
a right-sided eﬀusion, in a patient on peritoneal dialysis.
1.Introduction
Peritoneal dialysis (PD) is a well-established means of
renal replacement therapy. A Tenckhoﬀ catheter is electively
inserted into the peritoneal cavity before PD starts. After a
healing period of at least two weeks, PD training begins. In
our centre, 500ml volumes are used for the ﬁrst two days of
training and titrated upwards, based on body surface area,
over a two-week period.
In our centre, there are 35–40 patients on PD at any one
time. Approximately 2 patients join our program per month,
and a similar number exit the program due to transplan-
tation, switch to haemodialysis, or death. Patients starting
PD in our unit use standard dextrose-based, lactate-buﬀered
dialysate. If infusion pain is a problem, bicarbonate/lactate
buﬀered dialysate is used instead. A daytime icodextrin-
based dialysate dwell is often required in patients with little
residual renal function for extra ultraﬁltration. Icodextrin is
a hyperosmolar glucose polymer.
The main complications of PD are either infectious, such
as peritonitis and exit site infections, or pressure related,
suchasabdominalwallherniasandgastrooesophagealreﬂux.
Less frequently, a pleural eﬀusion containing dialysate can
develop. This phenomenon appears to be due to increased
intraabdominal pressure in the setting of congenital or
acquired diaphragmatic defects. The incidence rate of pleu-
roperitoneal leak development is thought to be less than
2% in newcomers to peritoneal dialysis [1]. We report three
cases of pleuroperitoneal leak that occurred within a nine-
month period atour institution. This corresponded to a 12%
incidence rate amongst newcomers to PD in that calendar
year(25newcomers).Priortothat,therehadbeennocasesin
ourdepartmentforover10years[2].Wereviewtheliterature
on this topic and discuss management options.
2.Case1
A 35-year-old Philipino female presented to our unit with
advanced chronic kidney disease, secondary to medullary2 International Journal of Nephrology
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Figure 1: Chest radiograph at presentation.
Table 1: Biochemical results.
Pleural ﬂuid Serum
pH 7.64 7.38
Albumin (g/dL) <15 32
HCO3—(mmol/L) 30.1 28
LDH (iu/L) <50 474
Glucose (mmol/L) 12.1 5.2
Amylase (iu/L) <10 40
cystickidneydisease,whichwasdiagnosedmanyyearsearlier
in the Philipines. She had no signiﬁcant heart disease. One
year later, she was approaching end-stage kidney disease and
aT enckhoﬀcatheterwasinserted.TrainingforPDbeganfour
weeks later, using standard dextrose-based solutions.
She presented after four days of PD training with
dyspnoea. She was otherwise well and was afebrile. Blood
tests and ECG were unchanged. She had clinical evidence
of a large, rightsided pleural eﬀusion. This was conﬁrmed
on a chest radiograph (Figure 1). A diagnostic aspirate
was performed and yielded serous ﬂuid. The pleural ﬂuid
biochemistry was consistent with a transudative process
(Table 1). The high-pleural-ﬂuid-serum-glucose ratio con-
ﬁrmed the clinical suspicion of a pleuroperitoneal leak.
The pleural eﬀusion resolved over a number of days
with conservative management and the maintenance of a dry
peritoneal cavity. A follow-up chest radiograph was normal
(Figure 2). In accordance with patient preference, PD was
discontinued. Haemodialysis (HD) access was established
and HD is ongoing one year later.
3.Case2
A 38-year-old Romanian female was admitted acutely with
symptomatic uraemia. Her background was signiﬁcant for
minimal change disease, diagnosed in 2001 in Romania. She
had received two courses of heavy immunosuppression for
this and was then lost to follow up. She had no known
heart disease. Her renal ultrasound showed small, shrunken
kidneys, which conﬁrmed the suspicion of advanced chronic
kidney disease.
L
Figure 2: Follow-up chest radiograph.
Table 2: Biochemical results.
Pleural ﬂuid Serum
pH 7.55 7.37
Albumin (g/dL) <15 39
HCO3—(mmol/L) 29 32
LDH (iu/L) <50 379
Glucose (mmol/L) 8.6 6.1
Acute HD was initiated but, as the patient’s preference
was for PD, a Tenckhoﬀ catheter was inserted. Five weeks
later, PD training began. Her target PD prescription con-
sisted of four cycles of two litre exchanges with standard
dextrose-based standard solution. She was also prescribed
one icodextrin-based dwell by day.
After six days of PD training, she presented with
dyspnoea that was exacerbated by infusing dialysate. She
had no other systemic symptoms. She was seven kg above
her dry weight and had clinical evidence of a rightsided
pleural eﬀusion and pedal oedema. Her electrocardiogram
(ECG) and routine blood tests were unchanged. As she
appeared volume overloaded, she had three litres of isolated
ultraﬁltration,usinghercentralvenouscatheter.Herdiuretic
regime was maximized and she was discharged.
Despite these interventions, she presented several days
later with worsening dyspnoea. A chest radiograph con-
ﬁrmed a large rightsided pleural eﬀusion. Again, she had 3
litres of isolated ultraﬁltration. With this, she developed bad
cramping. Therapeutic thoracocentesis was performed, with
the removal of 1.2 litres of serous ﬂuid. This led to marked
clinical and radiological resolution of the pleural eﬀusion.
Although the initial presumed diagnosis was volume
overload, the high pleural ﬂuid glucose relative to the serum
glucose conﬁrmed the presence of a pleuroperitoneal leak
(Table 2). In accordance with patient preference, PD was
discontinued and the Tenckhoﬀ catheter was removed. HD
is ongoing without complication.
4.Case3
Atwenty-four-year-oldIrishmalewithabackgroundhistory
of congenital deafness, intellectual impairment and repair of
a posterior urethral valve initially presented to the paediatricInternational Journal of Nephrology 3
Table 3: Biochemical results.
Pleural ﬂuid Serum
pH 7.23 7.36
Albumin (g/dL) 28 29
HCO3—(mmol/L) 20 26
LDH (iu/L) 2816 614
Glucose (mmol/L) <0.6 4
Amylase (iu/L) <10 32
nephrologyserviceswithnephroticsyndrome.Arenalbiopsy
revealed secondary focal segmental glomerulosclerosis and
signiﬁcant tubuleinterstitial ﬁbrosis. Following introduction
of Renin-Angiotensin-Aldosterone system blockade, his pro-
teinuria was controlled.
Despite this, his chronic kidney disease progressed. Ten
years later, he was approaching end-stage kidney disease. A
Tenckhoﬀ catheter was inserted without complication. Six
weeks later, PD training was initiated. A bicarbonate/lactate
buﬀered solution was used to avoid infusion pain, which he
would be unable to verbalise. The following months were
complicated by dialysis-associated pericarditis that resolved
with intensive haemodialysis for a number of weeks. His
baseline PD prescription consisted of seven cycles of two
litre exchanges with 1.36% dextrose solution. He was also
prescribed an icodextrin-based daytime dwell.
Five months later, he was admitted with clinical and
radiological evidence of a large, rightsided pleural eﬀusion
with pleural thickening. The exact duration of the eﬀusion
was unclear as he was unable to verbalise symptoms. It was
thought to have developed over weeks given the apparent
absence of symptoms and the degree of pleural thickening.
A chest radiograph four months earlier showed normal lung
ﬁelds.
He was afebrile and systemically well. His serum bio-
chemistry and haematology were unchanged and his inﬂam-
matory markers were not raised. ECG and echo were nor-
mal. A diagnostic pleural aspirate was performed under
ultrasound guidance. This yielded serous ﬂuid and also
identiﬁed numerous loculations within the collection.
The pleural ﬂuid biochemistry was atypical for that
seen with pleuroperitoneal leak (Table 3). However, as the
patient was so well clinically, and numerous pleural ﬂuid
cultures were sterile, it was felt that the eﬀusion was not
related to infection. It was also felt that the eﬀusion was
not due to volume overload given the degree of loculation
within the eﬀusion and the absence of other clinical signs
of volume overload. The low pleural ﬂuid glucose and high
lactatedehydrogenase(LDH)werediﬃculttointerpretasthe
sampledﬂuidwaswalledoﬀwithinaloculation,probablyfor
manyweeks.Aclinicaldiagnosisofpleuroperitonealleakwas
made and PD was discontinued.
The eﬀusion did not resolve with drainage of the
peritonealcavity,andachestdrainwasinserted.Thisdrained
minimal serous ﬂuid due to the highly loculated nature of
the eﬀusion. A second drain was inserted and intrapleural
alteplase administered. This drain became dislodged and was
replaced by a third drain with further intrapleural alteplase
administration. At this point, however, a chest radiograph
conﬁrmed persistence of the large, loculated eﬀusion with a
small pneumothorax and a thick pleural rind.
Video-assisted thorascopic surgery with decortication
was performed. A rapid postoperative recovery ensued and
the postoperative chest drains were removed without event.
A chest radiograph six weeks later showed a well-expanded
right lung, without eﬀusion or pleural abnormality. HD is
ongoing without complication.
5. Discussion
The ﬁrst description of a pleuroperitoneal leak causing a
pleural eﬀusion in a PD patient was in 1967 [3]. Since
then, several reports have estimated the incidence of this
complication; the largest report estimated an incidence of
1.6% [1].
Itisthoughtthatcongenitaloracquiredcommunications
between the pleura and peritoneum underpin this problem.
This had been demonstrated both in scintigraphy [4] and in
autopsy specimens with localized absence of diaphragmatic
muscle ﬁbres [5]. The raised intraabdominal pressure with
dialysate infusion, in a patient with such a communication,
promotesthetranslocationofdialysateintothepleuralspace.
An increased incidence of pleuroperitoneal leak is seen
in patients with polycystic kidney disease [6]. This is
probably related to the increased intraabdominal pressure
in these patients and, therefore, higher pleuroperitoneal
pressure gradients [6]. There is also a generalized connective
tissue weakness in this condition that may contribute to
inherent diaphragmatic weakness [6]. Patients with previous
peritonitisarealsoathigherriskofdevelopingthiscondition.
This is probably due to a weakening of diaphragmatic tissue
during peritonitis [7].
The timing of this complication varies from days to
years after the initiation of PD. Half of cases occur within
one month of starting PD [3]; these probably represent
patients with congenital diaphragmatic defects. Those cases
that occur later probably represent those with acquired
diaphragmatic defects. Patients typically present with dys-
pnoea, although a signiﬁcant proportion are asymptomatic
[3]. Clinical examination reveals a pleural eﬀusion that is
usually rightsided [3]. Presumably the preponderance of
rightsided cases is due to diaphragmatic protection by the
heart on the left.
Pleural eﬀusions are broadly divided into transudative
and exudative eﬀusions. Transudative eﬀusions develop
when systemic factors aﬀect the pleural Starling forces, as
seen, for example, in congestive cardiac failure. Exudative
eﬀusions develop when local factors inﬂuence the formation
ofpleuralﬂuid,asseeninmalignanteﬀusions.Light’scriteria
are applied to the pleural and serum biochemistry to make
the distinction between a transudate and an exudate [8]. An
eﬀusion is an exudate if the pleural-ﬂuid-to-serum-protein
ratio is >0.5 or the pleural-ﬂuid-to-serum-LDH ratio is
>0.6 [8]. Pleuroperitoneal leaks typically cause transudative
eﬀusions with low LDH and low cell count [5].
The diﬀerential diagnosis of a pleural eﬀu s i o ni na
dialysis patient is extensive. Transudative pleural eﬀusions4 International Journal of Nephrology
due to volume overload or congestive cardiac failure are
relatively common in this population. In PD patients, such
eﬀusions would typically be managed by increasing the
dialysate volume and tonicity to increase ultraﬁltration.
However, this can exacerbate the problem if the eﬀusion is
due to a pleuroperitoneal leak.
This highlights the importance of the pleural ﬂuid
glucose measurement. In the absence of loculation, a high
pleural ﬂuid to serum glucose concentration gradient is a
very sensitive and speciﬁc test for diagnosing a pleuroperi-
toneal leak [9]. The ratio of pleural ﬂuid to serum glucose is
dynamic, and varies depending on the type of ﬂuid instilled,
the volume and the contact time. However, a positive
gradient is highly suggestive of a pleuroperitoneal leak [9].
This is due to the presence of hypertonic, usually dextrose-
based, dialysate in the pleural space—a “sweet hydrothorax”
[10]. Atypical biochemistry can be seen when the ﬂuid has
been in the pleural cavity for a prolonged period and has
been partially reabsorbed by lymphatics, as seen in Case 3.
Other diagnostic tests are less practical and include
Technetium-99m labelled peritoneal scintigraphy [4]a n d
computed tomography (CT) with intraperitoneal dye [11].
In terms of management, emergency large volume thora-
cocentesis is occasionally required [3]. However, most cases
of pleuroperitoneal leak are initially managed by drainage of
the peritoneal cavity [3]. Temporary HD may be required,
especially for those with minimal residual renal function.
Manypatients choosetoremainonHDinthelongtermand,
therefore, formal repair of the diaphragm is not required.
ForthosethatwishtoreturntoPD,thereareanumberof
management options. One group advocates early diaphrag-
matic repair and continuation of peritoneal dialysis [12]. In
this case, thorascopic diaphragmatic repair was performed
using absorbable polyglycolic acid felt, and ﬁbrin glue [12].
Most advocate temporary discontinuation of PD. This
allows resolution of the eﬀusion and, in some cases, healing
of the diaphragmatic defects. A trial of low-volume PD two–
six weeks later is successful in a signiﬁcant proportion of
cases [13].
Recurrent hydrothorax necessitates either a permanent
switch to haemodialysis or deﬁnitive management of the
pleural-peritoneal communication. Chemical pleurodesis
via an intercostal drain has been used in several cases
with success [13]. Agents used include tetracycline, blood
and ﬁbrin glue. This method had relatively high rates of
success, with 48% of patients resuming long-term PD after
pleurodesis in one large systematic review [13].
Video-assisted thorascopic surgery, with direct visualiza-
tionofthediaphragmaticdefectandsuturerepair,hasshown
much promise in recent times for the management of this
condition [13, 14]. Using this approach, 88% of patients
in one study successfully resumed long-term PD without
recurrence [13].
The three cases described above highlight the variability
of this condition in terms of timing, symptoms, and
management. Pleuroperitoneal leak should be considered in
the diﬀerential diagnosis of a pleural eﬀusion, particularly a
rightsided eﬀusion, in a patient on peritoneal dialysis.
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